When drugmaker AstraZeneca closed down its research and development centre in Bangalore six years ago, some of the local scientists managed to find new jobs at a nearby biotech start-up. Since then, they have been working to tackle a problem which is causing concern among doctors in India and around the world: the human body’s increasing resistance to antibiotics.
6年前，當制藥商阿斯利康(AstraZeneca)關閉在班加羅爾的研發中心后，一些當地科學家設法在附近的一家生物科技初創企業找到新的工作。自那以來，他們一直致力于對付一個正在引起印度乃至世界各地醫生擔憂的問題：人體對抗生素日益增強的耐藥性。
您已閱讀4%（486字），剩余96%（11085字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。